Literature DB >> 21675430

Cancer survival in Harare, Zimbabwe, 1993-1997.

E Chokunonga1, M Z Borok, Z M Chirenje, A M Nyabakau, D M Parkin.   

Abstract

The Zimbabwe national cancer registry was established in 1985 as a population-based cancer registry covering Harare city. Cancer is not a notifiable disease, and registration of cases is done by active methods. The registry contributed data on randomly drawn sub-samples of Harare resident cases among 17 common cancer sites or types registered during 1993-1997 from black and white populations. Follow-up was carried out predominantly by active methods with median follow-up ranging from 1-54 months for different cancers. The proportion with histologically verified diagnosis for various cancers ranged from 20-100%; death certificate only (DCO) cases comprised 0-34%; 58-97% of total registered cases were included for survival analysis. Complete follow-up at five years ranged from 94-100%. Five-year age-standardized relative survival rates of selected cancers among both races combined were cervix (42%), breast (68%), Kaposi sarcoma (4%), liver (3%), oesophagus (12%), stomach (20%) and lung (14%). Survival was markedly higher among white than black populations for most cancers with adequate cases. Five-year relative survival by age group was fluctuating, with no definite pattern or trend.

Entities:  

Mesh:

Year:  2011        PMID: 21675430

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  5 in total

Review 1.  Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal.

Authors:  Tim Crocker-Buque; Allyson M Pollock
Journal:  J R Soc Med       Date:  2015-02       Impact factor: 5.344

Review 2.  Gastric cancer in Africa: current management and outcomes.

Authors:  Akwi W Asombang; Rubayat Rahman; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

3.  Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnoses.

Authors:  Satish Gopal; Robert Krysiak; N George Liomba; Marie-Josephe Horner; Carol G Shores; Noor Alide; Steve Kamiza; Coxcilly Kampani; Fred Chimzimu; Yuri Fedoriw; Dirk P Dittmer; Mina C Hosseinipour; Irving F Hoffman
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

4.  Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa.

Authors:  Esther Freeman; Aggrey Semeere; Megan Wenger; Mwebesa Bwana; F Chite Asirwa; Naftali Busakhala; Emmanuel Oga; Elima Jedy-Agba; Vivian Kwaghe; Kenneth Iregbu; Antoine Jaquet; Francois Dabis; Habakkuk Azinyui Yumo; Jean Claude Dusingize; David Bangsberg; Kathryn Anastos; Sam Phiri; Julia Bohlius; Matthias Egger; Constantin Yiannoutsos; Kara Wools-Kaloustian; Jeffrey Martin
Journal:  BMC Cancer       Date:  2016-02-06       Impact factor: 4.430

5.  Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.

Authors:  Aggrey Semeere; Esther Freeman; Megan Wenger; David Glidden; Mwebesa Bwana; Micheal Kanyesigye; Fredrick Chite Asirwa; Elyne Rotich; Naftali Busakhala; Emmanuel Oga; Elima Jedy-Agba; Vivian Kwaghe; Kenneth Iregbu; Clement Adebamowo; Antoine Jaquet; Francois Dabis; Sam Phiri; Julia Bohlius; Matthias Egger; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Jeffrey Martin
Journal:  BMC Cancer       Date:  2017-09-02       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.